Member Info for andyrp

wow - probably explains why UKOG has no IIs; Sanderson doesn’t want to be held to account.

An individual like Elon Musk can only influence the price for a short period of time, the market will always assign the right value eventually.

The fact we are being chosen by the NHS is hugely positive; the dispute would have caused a lot of uncertainty and this RNS, whilst value is not actually material, is GMs way of saying they are still supplying NHS.

Influential people can impact the SP for a few days but the market will always assign the right value longer term.

After a tough couple of weeks it feels ARB has settled down now and isn’t reacting so drastically to any fall in BTC price. Steadily upwards with BTC from here please. BTC will soon be $100,000 so huge upside for Argo before you even consider new machines, Nasdaq, Texas and the green aspects.

*** Edward Spencer.

Edwards have increased their position; that’s a good sign!

Feels like patience is on the verge of being rewarded; remember the stock market is a mechanism to move money from the impatient to the patient. This is a new solution with a new accounting asset class and whilst approved approved by some of the major accounting firms, as well as having a Sharia compliant solution (not easy to get) it takes time to bring something new to market.

However, it feels like that time is now and the recent Podcast has confirmed my belief in SYME to be right.

If we want to see the potential this share has just look at AAA; James Normand was a non-exec there as well as at RDGC and both AP and JM were significant investors. Join up the dots as they say!

Divide by 300. Shares were consolidated 300 shares to 1 share.

As I said before this is under the radar and presents a huge opportunity which investors are not picking up on. Yesterday’s rise will raise awareness but then again perhaps it’s best as it is without the herd and the traders and maybe we should enjoy the peace and quiet!

Well done - I thought I got in early at 34p!

The ARB share price has absolutely rocketed this year so a retrace and some consolidation shouldn’t be a surprise; this gives a good platform for the next leg up. Peter Wall has done a fantastic job and I think his communication is very open and transparent. He’s the sort of CEO you want; not corporate at all and has that quirky edge that the modern era of successful leaders need.

Those who are crazy enough to think they can change the world, are the ones that do!

It’s one hell of a discount; losing faith in INFA board now but will ride it out nevertheless.

It’s a nice gesture but is it material information? Mullis wouldn’t announce winning a contract to supply 1 million tests would he!

The Chartists missed this tell tale sign!

https://www.volcanodiscovery.com/earthquake/news/128737/Small-tremor-of-magnitude-31-just-reported-13-miles-east-of-Ridgecrest-California-United-States.html

You don’t get this elsewhere on LSE - Ghia and Merchantman with some slightly different opinions yet discussed maturely, amicably and sensibly. A refreshing change on the LSE boards. Long may it continue!!!!

aj242 I'm a Director in the pharma industry and I can assure you that not every pharma co wants to be in the ABPI!

ABPI is a voluntary organisation and only its members are bound by the ABPI code of conduct. Non-members are not bound by the ABPI code but are bound by general regulations regarding marketing of medicinal products (like everyone else) and this limits the claims that can be made but not enthusiasm and passion for the medicinal product being promoted / marketed.

As daveboy19 posted "They have hammered this point home with as lacklustre presentation I have seen"; whilst I didn't watch the presentation (clashed with another) but I was watching the SP I my immediate thought was that despite a decent RNS the company wasn't inspiring confidence in the presentation and the market has taken advantage.

The drug works, the science is right and there is still huge demand and the company needs to capitalise on this asap.